|
Biomarin Pharmaceutical Inc. (BMRN) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
BioMarin Pharmaceutical Inc. (BMRN) Bundle
Conçu pour la précision, notre calculatrice DCF [BMRN] vous permet d'évaluer l'évaluation de Biomarin Pharmaceutical Inc. à l'aide de données financières à jour et d'adaptabilité complète pour modifier tous les paramètres essentiels pour les prévisions améliorées.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,860.5 | 1,846.3 | 2,096.0 | 2,419.2 | 2,853.9 | 3,183.2 | 3,550.5 | 3,960.2 | 4,417.1 | 4,926.7 |
| Revenue Growth, % | 0 | -0.76218 | 13.53 | 15.42 | 17.97 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 |
| EBITDA | -5.9 | 48.0 | 267.5 | 310.3 | 650.5 | 322.6 | 359.8 | 401.3 | 447.6 | 499.3 |
| EBITDA, % | -0.31444 | 2.6 | 12.76 | 12.83 | 22.79 | 10.13 | 10.13 | 10.13 | 10.13 | 10.13 |
| Depreciation | 105.9 | 108.0 | 102.0 | 104.4 | 96.4 | 153.4 | 171.1 | 190.9 | 212.9 | 237.5 |
| Depreciation, % | 5.69 | 5.85 | 4.86 | 4.31 | 3.38 | 4.82 | 4.82 | 4.82 | 4.82 | 4.82 |
| EBIT | -111.7 | -60.0 | 165.5 | 205.9 | 554.1 | 169.1 | 188.7 | 210.4 | 234.7 | 261.8 |
| EBIT, % | -6.01 | -3.25 | 7.9 | 8.51 | 19.42 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 |
| Total Cash | 1,065.4 | 1,013.9 | 1,291.5 | 1,073.8 | 1,137.7 | 1,642.8 | 1,832.4 | 2,043.8 | 2,279.6 | 2,542.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 448.4 | 373.4 | 461.3 | 633.7 | 660.5 | 736.4 | 821.4 | 916.2 | 1,021.9 | 1,139.8 |
| Account Receivables, % | 24.1 | 20.22 | 22.01 | 26.19 | 23.14 | 23.13 | 23.13 | 23.13 | 23.13 | 23.13 |
| Inventories | 698.5 | 776.7 | 894.1 | 1,107.2 | 1,232.7 | 1,344.8 | 1,499.9 | 1,673.0 | 1,866.0 | 2,081.3 |
| Inventories, % | 37.55 | 42.07 | 42.66 | 45.77 | 43.19 | 42.25 | 42.25 | 42.25 | 42.25 | 42.25 |
| Accounts Payable | 191.4 | 193.0 | 231.2 | 315.5 | 235.4 | 337.8 | 376.8 | 420.3 | 468.8 | 522.9 |
| Accounts Payable, % | 10.29 | 10.45 | 11.03 | 13.04 | 8.25 | 10.61 | 10.61 | 10.61 | 10.61 | 10.61 |
| Capital Expenditure | -137.5 | -119.2 | -131.5 | -107.6 | -85.4 | -175.5 | -195.7 | -218.3 | -243.5 | -271.6 |
| Capital Expenditure, % | -7.39 | -6.46 | -6.28 | -4.45 | -2.99 | -5.51 | -5.51 | -5.51 | -5.51 | -5.51 |
| Tax Rate, % | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 |
| EBITAT | 2,254.6 | -51.0 | 156.7 | 183.1 | 436.6 | 117.5 | 131.1 | 146.2 | 163.1 | 181.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1,267.5 | -63.8 | -40.0 | -121.4 | 215.2 | 9.9 | -94.7 | -105.6 | -117.8 | -131.4 |
| WACC, % | 5.14 | 5.29 | 5.3 | 5.29 | 5.28 | 5.26 | 5.26 | 5.26 | 5.26 | 5.26 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -364.2 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -137 | |||||||||
| Terminal Value | -10,845 | |||||||||
| Present Terminal Value | -8,393 | |||||||||
| Enterprise Value | -8,758 | |||||||||
| Net Debt | -340 | |||||||||
| Equity Value | -8,417 | |||||||||
| Diluted Shares Outstanding, MM | 197 | |||||||||
| Equity Value Per Share | -42.79 |
What You Will Get
- Real BMRN Financial Data: Pre-filled with BioMarin's historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See BioMarin’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Real-Life BMRN Data: Pre-filled with BioMarin's historical financials and future growth estimates.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on user-defined inputs.
- Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
- User-Friendly Design: Intuitive layout, crafted for both industry professionals and newcomers.
How It Works
- Download: Obtain the pre-built Excel file containing BioMarin Pharmaceutical Inc. (BMRN) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and instantly compare results.
- Make Decisions: Utilize the valuation findings to inform your investment strategy.
Why Choose This Calculator for BioMarin Pharmaceutical Inc. (BMRN)?
- Accurate Data: Real BioMarin financials guarantee trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-built calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the pharmaceutical sector.
- User-Friendly: Easy-to-navigate design and comprehensive instructions ensure accessibility for all users.
Who Should Use This Product?
- Pharmaceutical Students: Explore drug development processes and apply them using real-world case studies.
- Researchers: Integrate advanced biopharmaceutical models into academic projects or publications.
- Investors: Evaluate your investment strategies and analyze valuation metrics for BioMarin Pharmaceutical Inc. (BMRN).
- Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model tailored for the biotech sector.
- Healthcare Entrepreneurs: Understand the valuation methods applied to leading biotech firms like BioMarin Pharmaceutical Inc. (BMRN).
What the Template Contains
- Pre-Filled DCF Model: BioMarin Pharmaceutical Inc.’s (BMRN) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate BioMarin’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.